Ozkan, A. Et Al. 2022. The Impact of Visible Tumor (PI-RADS >= 3) on Upgrading and Adverse Pathology at Radical Prostatectomy in Low Risk Prostate Cancer Patients: A Biopsy Core Based Analysis. CLINICAL GENITOURINARY CANCER , vol.20, no.1 .

Ozkan, A., Koseoglu, E., Kilic, M., Baydar, D. E., Saglican, Y., Balbay, M. D., ... Canda, A. E.(2022). The Impact of Visible Tumor (PI-RADS >= 3) on Upgrading and Adverse Pathology at Radical Prostatectomy in Low Risk Prostate Cancer Patients: A Biopsy Core Based Analysis. CLINICAL GENITOURINARY CANCER , vol.20, no.1.

Ozkan, Arif Et Al. "The Impact of Visible Tumor (PI-RADS >= 3) on Upgrading and Adverse Pathology at Radical Prostatectomy in Low Risk Prostate Cancer Patients: A Biopsy Core Based Analysis," CLINICAL GENITOURINARY CANCER , vol.20, no.1, 2022

Ozkan, Arif Et Al. "The Impact of Visible Tumor (PI-RADS >= 3) on Upgrading and Adverse Pathology at Radical Prostatectomy in Low Risk Prostate Cancer Patients: A Biopsy Core Based Analysis." CLINICAL GENITOURINARY CANCER , vol.20, no.1, 2022

Ozkan, A. Et Al. (2022) . "The Impact of Visible Tumor (PI-RADS >= 3) on Upgrading and Adverse Pathology at Radical Prostatectomy in Low Risk Prostate Cancer Patients: A Biopsy Core Based Analysis." CLINICAL GENITOURINARY CANCER , vol.20, no.1.

@article{article, author={Arif Ozkan Et Al. }, title={The Impact of Visible Tumor (PI-RADS >= 3) on Upgrading and Adverse Pathology at Radical Prostatectomy in Low Risk Prostate Cancer Patients: A Biopsy Core Based Analysis}, journal={CLINICAL GENITOURINARY CANCER}, year=2022}